首页 工具
登录
购物车

搜索结果

Search Results for " btk in 1 "

如果没找到您满意的产品或者您对产品有其他要求,可以联系我们专业顾问为您提供针对性的合理建议。     QQ咨询       网站留言咨询

提交您的定制咨询

点击图片重新获取验证码
Cat. No. Product Name Target Signaling Pathways
TQ0230 BTK IN-1

SNS062 analog

BTK Angiogenesis; Tyrosine Kinase/Adaptors
BTK IN-1 (SNS062 analog) (SNS062 analog) 是一种有效的 BTK 抑制剂 (IC50<100 nM)。
T9814 JAK3/BTK-IN-1

JAK; BTK Angiogenesis; Chromatin/Epigenetic; JAK/STAT signaling; Stem Cells; Tyrosine Kinase/Adaptors
JAK3/BTK- in -1是一种特异性靶向和抑制Janus 激酶3 (JAK3)和布鲁顿酪氨酸激酶(BTK)的JAK3/BTK 双重抑制剂 ,BTK 和 JAK3 是自身免疫性疾病的两个重要靶点。JAK3/BTK- in -1同时抑制 BTK/JAK3 信号通路表现出协同效应。 JAK3/BTK- in -1是治疗免疫相关疾病(如自身免疫性疾病、某些类型的癌症(包括淋巴瘤和白血病)以及可能以免疫反应失调为特征的其他疾病)的潜在化合物。
T14692 BMX-IN-1

BMX kinase inhibitor

BTK Angiogenesis; Tyrosine Kinase/Adaptors
BMX-IN-1 (BMX kinase inhibitor) 是 X 染色体上的骨髓酪氨酸激酶 (BMX, IC50 = 8 nM) 和相关的布鲁顿酪氨酸激酶 (BTK, IC50 = 10.4 nM) 的特异性抑制剂,但 BMX-IN-1 对 Blk、JAK3、EGFR、Itk 或 Tec 活性的效力要低 47-656 倍以上。
T35330 BTK inhibitor 1

BTK Angiogenesis; Tyrosine Kinase/Adaptors
BTK inhibitor 1 (Compound 27)是一种BTK 抑制剂(IC50:0.11nM),对hWB 中的B 细胞活化具有抑制作用,IC50为2nM。
T36297 Btk inhibitor 1 hydrochloride

Btk inhibitor 1 Hcl is a pyrazolo[3,4-d]pyrimidine derivative as a Btk kinase inhibitor.IC50 value:Target: BtkFrom PCT Int. Appl. (2012), WO 2012158843 A2 20121122. [1]. PCT Int. Appl. (2012), WO 2012158843 A2 20121122.
T74636 PROTAC BTK Degrader-1

PROTACBTK Degrader-1 是一种有效且具有选择性和口服活性的PROTACBTK 降解剂,对野生型BTK 和突变型 BTK-481S 的IC50分别为 34.51 nM 和 64.56 nM。PROTACBTK Degrader-1 能有效降低BTK 蛋白水平,抑制肿瘤生长。
T16730 Remibrutinib

BTK Angiogenesis; Tyrosine Kinase/Adaptors
Remibrutinib 是有效的、口服具有活力的 bruton tyrosine kinase 抑制剂 (IC50:1 nM),在血液中抑制 BTK 活性的 IC50的值为 0.23 μM。它具有研究慢性荨麻疹的潜力。
T36287 Pirtobrutinib

BTK Angiogenesis; Tyrosine Kinase/Adaptors
Pirtobrutinib (LOXO-305) is an advanced BTK inhibitor that displays high selectivity and operates through a non-covalent mechanism. This compound effectively inhibits various BTK C481 substitution mutations, leading to tumor regression in BTK-dependent lymphoma tumors in mouse xenograft models. Furthermore, Pirtobrutinib exhibits remarkable selectivity for BTK, with more than a 300-fold difference compared to 370 other kinases tested. Notably, at a concentration of 1 μM, Pirtobrutinib demonstrat...
T17319 1,2-Bis(2-iodoethoxy)ethane

Others; PROTAC Linker Others; PROTAC
1,2-Bis(2-iodoethoxy)ethane 是一种属于 PEG 类的 PROTAC linker,可用于 MT802 和 SJF620 的合成。其中 MT-802 和 SJF620 都是 PROTAC BTK 降解剂,DC50分别为 1 和 7.9 nM。
T73275 BTK-IN-22

BTK-IN-22 是一种BTK 抑制剂 (IC50: 12.8 nM)。BTK-IN-22 还抑制 BLX 和 BMX,IC50分别为 35.6 和 5.7 nM。与 Ibrutinib 相比,BTK-IN-22 显示出更高的激酶选择性。
T73319 BTK-IN-19

BTK-IN-19 是一种可逆的BTK 抑制剂,IC50<0.001 μM。
T79113 BTK-IN-25

BTK Angiogenesis; Tyrosine Kinase/Adaptors
BTK-IN-25(compound 71)作为BTK抑制剂,展现出对BTK(C481S)的强效抑制作用,IC50为0.77 nM。该化合物在DOHH2细胞中对BTK亦表现出高效抑制,IC50为1 nM。
T75124 BTK-IN-24

BTK-IN-24 (compound 195) 是一种有效的BTK 抑制剂,通过泛素蛋白水解途径降解BTK
T73276 BTK-IN-23

BTK-IN-23 是一种BTK 抑制剂 (IC50: 12.8 nM)。BTK-IN-23 还抑制 BLX 和 BMX,IC50分别为 35.6 和 5.7 nM。与 Ibrutinib 相比,BTK-IN-23 显示出更高的激酶选择性。
T16614 Propargyl-PEG4-acid

Others Others
Propargyl-PEG4-acid is a PEG-based PROTAC linker can be used in the synthesis of BTK-IAP PROTACs Ibrutinib -based PROTAC 2 and an analogue PROTAC 3. PROTAC 3 causes BTK degradation with a DC50 of 200 nM in THP-1 cells[1].
T79292 PROTAC BTK Degrader-5

BTK Angiogenesis; Tyrosine Kinase/Adaptors
PROTACBTK Degrader-5 (compound 3e) 是一种BTK选择性降解剂,其在JeKo-1细胞中的DC50为7.0 nM。该化合物对CRBN新基态显示出无脱靶活性,且对淋巴瘤细胞表现出抗增殖效果,适用于恶性淋巴瘤的研究1
T77928 PROTAC PTK6 ligand-1

Ligands for Target Protein for PROTAC PROTAC
PROTACPTK6 ligand-1是用于合成BTK激酶抑制剂的中间体,也可作为ARD-61合成的原料。
T35481 DD 03-171

Potent and selective BTK Degrader (IC50 = 5.1 nM); degrades BTK in a proteasome- and CRBN-dependent manner. Suppresses BTK signaling and proliferation in mantle cell lymphoma (MCL) cells by degrading BTK, IKFZ1, and IKFZ3 (3 validated targets in B-cell malignancies). Also degrades Ibrutinib (Cat. No. 6813) -resistant C481S-BTK mutant cancer cells. Exhibits no binding against a panel of 468 kinases at 1 μM. Reduces tumor burden and extends survival in lymphoma patient-derived xenograft models.
T79067 PROTAC BTK Degrader-3

PROTACs PROTAC
PROTACBTK Degrader-3为BTKPROTAC降解剂,具有效力,其在Mino细胞中BTK降解的DC50值为10.9 nM。该降解剂具有应用于研究B细胞恶性肿瘤潜力,包括慢性淋巴细胞恶性肿瘤。
T63959 BLK-IN-1

BLK-IN-1 是一种选择性的、共价的 B-淋巴酪氨酸激酶 (BLK) 和 BTK 抑制剂,他们的 IC50 值分别为 18.8 nM 和 20.5 nM。BLK-IN-1 能够用于研究癌症。
T37085 Luxeptinib

Luxeptinib (CG-806) is a novel pan-FLT3/pan-BTK inhibitor that is administered orally. It exhibits potent and reversible inhibition of these enzymes, acting through a non-covalent mechanism. Luxeptinib effectively induces cell cycle arrest, apoptosis, or autophagy in acute myeloid leukemia cells [1][2][3][4].
T79019 JNJ-64264681

BTK Angiogenesis; Tyrosine Kinase/Adaptors
JNJ-64264681为一种高效的口服可活性选择性不可逆共价BTK抑制剂,展现出优良的药物代谢动力学属性,适用于癌症与自身免疫性疾病领域研究。
T79812 BTK-IN-27

BTK Angiogenesis; Tyrosine Kinase/Adaptors
BTK-IN-27(示例8)作为一种BTK抑制剂,具有高效的IC50值为0.2 nM。在TMD8细胞中,该化合物展现出显著的抗增殖能力,IC50值低于5 nM。BTK-IN-27适用于癌症、淋巴瘤、白血病及免疫性疾病研究领域。
T79201 PTD10

PROTACs PROTAC
PTD10是一种有效的PROTACBTK降解剂(DC50: 0.5 nM,KD: 2.28nM)。在Ramos和JeKo-1细胞系中,PTD10能够降解BTK,其DC50s分别为0.5和0.6 nM。此外,PTD10通过激活caspase依赖途径和线粒体途径抑制细胞增殖,诱导细胞凋亡(apoptosis),可作为研究B细胞失调模型的工具。
T82010 JDB175

BTK Angiogenesis; Tyrosine Kinase/Adaptors
JDB175是一种具有口服活性的高选择性BTK抑制剂,能够有效穿透血脑屏障。在中枢神经系统淋巴瘤的小鼠模型中,JDB175显示出良好的抗肿瘤活性,并未观察到显著毒性。它能有效地抑制人淋巴瘤细胞的BTK信号通路,阻止细胞周期,促进细胞凋亡。
T18068 Lenalidomide-PEG3-iodine

Others Others
Lenalidomide-PEG3-iodine, an E3 ligase ligand-linker conjugate, consists of a cereblon-based Lenalidomide ligand and a 3-unit polyethylene glycol (PEG) linker. This compound is utilized in creating various proteolysis targeting chimeras (PROTACs), including the highly effective PROTAC BTK degrader SJF620, which has a degradation concentration 50 (DC50) of 7.9 nM[1].
T36421 Immuno-Oncology Screening Library

The Immuno-Oncology Screening Library consists of 2 plates and contains more than 90 cancer and immunology-associated compounds in a 96-well Matrix tube rack format as 10 mM stock solutions in DMSO. This library includes a variety of immuno-oncology target modulators, including but not limited to, adenosine, CCR, CXCR, and TLR agonists and antagonists, BTK, PI3K, VEGFR, and BRAF inhibitors, PD-1/PDL-1 interaction inhibitors, and HDAC inhibitors. Please review the product insert for a full list ...
T73942 (Rac)-IBT6A hydrochloride

(Rac)-IBT6A hydrochloride 是 IBT6A hydrochloride 的消旋体。IBT6A 是 Ibrutinib 的一种杂质。IBT6A 可用于合成 IBT6A-Ibrutinib 二聚体和 IBT6A 加合物。Ibrutinib 是一种不可逆的选择性 Btk 抑制剂,IC50为 0.5 nM。
T83911 CYY292

CYY292是一种针对PDGFRα、PDGFRβ、FGFR1、-2和-3的抑制剂(IC50分别为5.35、4.6、28、28和78 nM)。该化合物对这些激酶的选择性高于FGFR4(IC50 > 1,000 nM),但也能抑制c-Kit、VEGFR2、VEGFR1和胰岛素样生长因子1受体(IGF-1R;IC50分别为67、33、36和75 nM),以及EGFR、布鲁顿酪氨酸激酶(BTK)、细胞周期依赖性激酶4(Cdk4)/cyclin D3和MET(IC50分别为128、198、214和396 nM)。CYY292抑制MG-63、U2OS、MNNG/HOS和Saos-2骨肉瘤细胞的增殖(IC50分别为0.84、0.76、1.36和0.72 µM)。在0.3和0.5 µM的浓度下,它抑制U87MG和LN-229胶质母细胞瘤细胞的迁移和侵袭。CYY292(30 mg/kg)在U87MG原位小鼠异种移植模型中降低肿瘤体积并增加生存率。

化合物

BTK IN-1
Cat.No: TQ0230
Synonym: SNS062 analog
Target: BTK
JAK3/BTK-IN-1
Cat.No: T9814
Synonym:
Target: JAK, BTK
BMX-IN-1
Cat.No: T14692
Synonym: BMX kinase inhibitor
Target: BTK
BTK inhibitor 1
Cat.No: T35330
Synonym:
Target: BTK
Btk inhibitor 1 hydrochloride
Cat.No: T36297
Synonym:
Target:
PROTAC BTK Degrader-1
Cat.No: T74636
Synonym:
Target:
Remibrutinib
Cat.No: T16730
Synonym:
Target: BTK
Pirtobrutinib
Cat.No: T36287
Synonym:
Target: BTK
1,2-Bis(2-iodoethoxy)ethane
Cat.No: T17319
Synonym:
Target: Others, PROTAC Linker
BTK-IN-22
Cat.No: T73275
Synonym:
Target:
BTK-IN-19
Cat.No: T73319
Synonym:
Target:
BTK-IN-25
Cat.No: T79113
Synonym:
Target: BTK
BTK-IN-24
Cat.No: T75124
Synonym:
Target:
BTK-IN-23
Cat.No: T73276
Synonym:
Target:
Propargyl-PEG4-acid
Cat.No: T16614
Synonym:
Target: Others
PROTAC BTK Degrader-5
Cat.No: T79292
Synonym:
Target: BTK
PROTAC PTK6 ligand-1
Cat.No: T77928
Synonym:
Target: Ligands for Target Protein for PROTAC
DD 03-171
Cat.No: T35481
Synonym:
Target:
PROTAC BTK Degrader-3
Cat.No: T79067
Synonym:
Target: PROTACs
BLK-IN-1
Cat.No: T63959
Synonym:
Target:
Luxeptinib
Cat.No: T37085
Synonym:
Target:
JNJ-64264681
Cat.No: T79019
Synonym:
Target: BTK
BTK-IN-27
Cat.No: T79812
Synonym:
Target: BTK
PTD10
Cat.No: T79201
Synonym:
Target: PROTACs
JDB175
Cat.No: T82010
Synonym:
Target: BTK
Lenalidomide-PEG3-iodine
Cat.No: T18068
Synonym:
Target: Others
Immuno-Oncology Screening Library
Cat.No: T36421
Synonym:
Target:
(Rac)-IBT6A hydrochloride
Cat.No: T73942
Synonym:
Target:
CYY292
Cat.No: T83911
Synonym:
Target:
TargetMol Loading
联系我们
400-820-0310

上海市静安区江场三路238号8楼